Click for best price
Rheumatology Arthritis Therapeutics Market Size, Share 2024
The global Rheumatology Arthritis Therapeutics market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Topical Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Rheumatology Arthritis Therapeutics include AbbVie, Boehringer Ingelheim GmbH, Novartis AG, Regeneron Pharmaceuticals, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., UCB S.A. and Johnson & Johnson Services, Inc., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Rheumatology Arthritis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatology Arthritis Therapeutics. This report contains market size and forecasts of Rheumatology Arthritis Therapeutics in global, including the following market information:
Global Rheumatology Arthritis Therapeutics Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Rheumatology Arthritis Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rheumatology Arthritis Therapeutics Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Rheumatology Arthritis Therapeutics Market Segment Percentages, by Type, 2023 (%)
Topical
Oral
Parenteral
Global Rheumatology Arthritis Therapeutics Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Rheumatology Arthritis Therapeutics Market Segment Percentages, by Application, 2023 (%)
Hospitals
Clinics
Others
Global Rheumatology Arthritis Therapeutics Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Rheumatology Arthritis Therapeutics Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rheumatology Arthritis Therapeutics revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Rheumatology Arthritis Therapeutics revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Boehringer Ingelheim GmbH
Novartis AG
Regeneron Pharmaceuticals, Inc.
Pfizer, Inc.
Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd.
UCB S.A.
Johnson & Johnson Services, Inc.
Amgen, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Rheumatology Arthritis Therapeutics, market overview.
Chapter 2: Global Rheumatology Arthritis Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Rheumatology Arthritis Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rheumatology Arthritis Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Rheumatology Arthritis Therapeutics Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Rheumatology Arthritis Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rheumatology Arthritis Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rheumatology Arthritis Therapeutics Overall Market Size
2.1 Global Rheumatology Arthritis Therapeutics Market Size: 2023 VS 2030
2.2 Global Rheumatology Arthritis Therapeutics Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Rheumatology Arthritis Therapeutics Players in Global Market
3.2 Top Global Rheumatology Arthritis Therapeutics Companies Ranked by Revenue
3.3 Global Rheumatology Arthritis Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Rheumatology Arthritis Therapeutics Companies in Global Market, by Revenue in 2023
3.5 Global Companies Rheumatology Arthritis Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Rheumatology Arthritis Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Rheumatology Arthritis Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Rheumatology Arthritis Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Rheumatology Arthritis Therapeutics Market Size Markets, 2023 & 2030
4.1.2 Topical
4.1.3 Oral
4.1.4 Parenteral
4.2 By Type - Global Rheumatology Arthritis Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Rheumatology Arthritis Therapeutics Revenue, 2019-2024
4.2.2 By Type - Global Rheumatology Arthritis Therapeutics Revenue, 2025-2030
4.2.3 By Type - Global Rheumatology Arthritis Therapeutics Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Rheumatology Arthritis Therapeutics Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Rheumatology Arthritis Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Rheumatology Arthritis Therapeutics Revenue, 2019-2024
5.2.2 By Application - Global Rheumatology Arthritis Therapeutics Revenue, 2025-2030
5.2.3 By Application - Global Rheumatology Arthritis Therapeutics Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Rheumatology Arthritis Therapeutics Market Size, 2023 & 2030
6.2 By Region - Global Rheumatology Arthritis Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Rheumatology Arthritis Therapeutics Revenue, 2019-2024
6.2.2 By Region - Global Rheumatology Arthritis Therapeutics Revenue, 2025-2030
6.2.3 By Region - Global Rheumatology Arthritis Therapeutics Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Rheumatology Arthritis Therapeutics Revenue, 2019-2030
6.3.2 US Rheumatology Arthritis Therapeutics Market Size, 2019-2030
6.3.3 Canada Rheumatology Arthritis Therapeutics Market Size, 2019-2030
6.3.4 Mexico Rheumatology Arthritis Therapeutics Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Rheumatology Arthritis Therapeutics Revenue, 2019-2030
6.4.2 Germany Rheumatology Arthritis Therapeutics Market Size, 2019-2030
6.4.3 France Rheumatology Arthritis Therapeutics Market Size, 2019-2030
6.4.4 U.K. Rheumatology Arthritis Therapeutics Market Size, 2019-2030
6.4.5 Italy Rheumatology Arthritis Therapeutics Market Size, 2019-2030
6.4.6 Russia Rheumatology Arthritis Therapeutics Market Size, 2019-2030
6.4.7 Nordic Countries Rheumatology Arthritis Therapeutics Market Size, 2019-2030
6.4.8 Benelux Rheumatology Arthritis Therapeutics Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Rheumatology Arthritis Therapeutics Revenue, 2019-2030
6.5.2 China Rheumatology Arthritis Therapeutics Market Size, 2019-2030
6.5.3 Japan Rheumatology Arthritis Therapeutics Market Size, 2019-2030
6.5.4 South Korea Rheumatology Arthritis Therapeutics Market Size, 2019-2030
6.5.5 Southeast Asia Rheumatology Arthritis Therapeutics Market Size, 2019-2030
6.5.6 India Rheumatology Arthritis Therapeutics Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Rheumatology Arthritis Therapeutics Revenue, 2019-2030
6.6.2 Brazil Rheumatology Arthritis Therapeutics Market Size, 2019-2030
6.6.3 Argentina Rheumatology Arthritis Therapeutics Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Rheumatology Arthritis Therapeutics Revenue, 2019-2030
6.7.2 Turkey Rheumatology Arthritis Therapeutics Market Size, 2019-2030
6.7.3 Israel Rheumatology Arthritis Therapeutics Market Size, 2019-2030
6.7.4 Saudi Arabia Rheumatology Arthritis Therapeutics Market Size, 2019-2030
6.7.5 UAE Rheumatology Arthritis Therapeutics Market Size, 2019-2030
7 Rheumatology Arthritis Therapeutics Companies Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Rheumatology Arthritis Therapeutics Major Product Offerings
7.1.4 AbbVie Rheumatology Arthritis Therapeutics Revenue in Global Market (2019-2024)
7.1.5 AbbVie Key News & Latest Developments
7.2 Boehringer Ingelheim GmbH
7.2.1 Boehringer Ingelheim GmbH Company Summary
7.2.2 Boehringer Ingelheim GmbH Business Overview
7.2.3 Boehringer Ingelheim GmbH Rheumatology Arthritis Therapeutics Major Product Offerings
7.2.4 Boehringer Ingelheim GmbH Rheumatology Arthritis Therapeutics Revenue in Global Market (2019-2024)
7.2.5 Boehringer Ingelheim GmbH Key News & Latest Developments
7.3 Novartis AG
7.3.1 Novartis AG Company Summary
7.3.2 Novartis AG Business Overview
7.3.3 Novartis AG Rheumatology Arthritis Therapeutics Major Product Offerings
7.3.4 Novartis AG Rheumatology Arthritis Therapeutics Revenue in Global Market (2019-2024)
7.3.5 Novartis AG Key News & Latest Developments
7.4 Regeneron Pharmaceuticals, Inc.
7.4.1 Regeneron Pharmaceuticals, Inc. Company Summary
7.4.2 Regeneron Pharmaceuticals, Inc. Business Overview
7.4.3 Regeneron Pharmaceuticals, Inc. Rheumatology Arthritis Therapeutics Major Product Offerings
7.4.4 Regeneron Pharmaceuticals, Inc. Rheumatology Arthritis Therapeutics Revenue in Global Market (2019-2024)
7.4.5 Regeneron Pharmaceuticals, Inc. Key News & Latest Developments
7.5 Pfizer, Inc.
7.5.1 Pfizer, Inc. Company Summary
7.5.2 Pfizer, Inc. Business Overview
7.5.3 Pfizer, Inc. Rheumatology Arthritis Therapeutics Major Product Offerings
7.5.4 Pfizer, Inc. Rheumatology Arthritis Therapeutics Revenue in Global Market (2019-2024)
7.5.5 Pfizer, Inc. Key News & Latest Developments
7.6 Bristol-Myers Squibb Company
7.6.1 Bristol-Myers Squibb Company Company Summary
7.6.2 Bristol-Myers Squibb Company Business Overview
7.6.3 Bristol-Myers Squibb Company Rheumatology Arthritis Therapeutics Major Product Offerings
7.6.4 Bristol-Myers Squibb Company Rheumatology Arthritis Therapeutics Revenue in Global Market (2019-2024)
7.6.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.7 F. Hoffmann-La Roche Ltd.
7.7.1 F. Hoffmann-La Roche Ltd. Company Summary
7.7.2 F. Hoffmann-La Roche Ltd. Business Overview
7.7.3 F. Hoffmann-La Roche Ltd. Rheumatology Arthritis Therapeutics Major Product Offerings
7.7.4 F. Hoffmann-La Roche Ltd. Rheumatology Arthritis Therapeutics Revenue in Global Market (2019-2024)
7.7.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.8 UCB S.A.
7.8.1 UCB S.A. Company Summary
7.8.2 UCB S.A. Business Overview
7.8.3 UCB S.A. Rheumatology Arthritis Therapeutics Major Product Offerings
7.8.4 UCB S.A. Rheumatology Arthritis Therapeutics Revenue in Global Market (2019-2024)
7.8.5 UCB S.A. Key News & Latest Developments
7.9 Johnson & Johnson Services, Inc.
7.9.1 Johnson & Johnson Services, Inc. Company Summary
7.9.2 Johnson & Johnson Services, Inc. Business Overview
7.9.3 Johnson & Johnson Services, Inc. Rheumatology Arthritis Therapeutics Major Product Offerings
7.9.4 Johnson & Johnson Services, Inc. Rheumatology Arthritis Therapeutics Revenue in Global Market (2019-2024)
7.9.5 Johnson & Johnson Services, Inc. Key News & Latest Developments
7.10 Amgen, Inc.
7.10.1 Amgen, Inc. Company Summary
7.10.2 Amgen, Inc. Business Overview
7.10.3 Amgen, Inc. Rheumatology Arthritis Therapeutics Major Product Offerings
7.10.4 Amgen, Inc. Rheumatology Arthritis Therapeutics Revenue in Global Market (2019-2024)
7.10.5 Amgen, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Rheumatology Arthritis Therapeutics Market Opportunities & Trends in Global Market
Table 2. Rheumatology Arthritis Therapeutics Market Drivers in Global Market
Table 3. Rheumatology Arthritis Therapeutics Market Restraints in Global Market
Table 4. Key Players of Rheumatology Arthritis Therapeutics in Global Market
Table 5. Top Rheumatology Arthritis Therapeutics Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Rheumatology Arthritis Therapeutics Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Rheumatology Arthritis Therapeutics Revenue Share by Companies, 2019-2024
Table 8. Global Companies Rheumatology Arthritis Therapeutics Product Type
Table 9. List of Global Tier 1 Rheumatology Arthritis Therapeutics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rheumatology Arthritis Therapeutics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Rheumatology Arthritis Therapeutics Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Rheumatology Arthritis Therapeutics Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Rheumatology Arthritis Therapeutics Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Rheumatology Arthritis Therapeutics Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Rheumatology Arthritis Therapeutics Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Rheumatology Arthritis Therapeutics Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2025-2030
Table 30. AbbVie Company Summary
Table 31. AbbVie Rheumatology Arthritis Therapeutics Product Offerings
Table 32. AbbVie Rheumatology Arthritis Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 33. AbbVie Key News & Latest Developments
Table 34. Boehringer Ingelheim GmbH Company Summary
Table 35. Boehringer Ingelheim GmbH Rheumatology Arthritis Therapeutics Product Offerings
Table 36. Boehringer Ingelheim GmbH Rheumatology Arthritis Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 37. Boehringer Ingelheim GmbH Key News & Latest Developments
Table 38. Novartis AG Company Summary
Table 39. Novartis AG Rheumatology Arthritis Therapeutics Product Offerings
Table 40. Novartis AG Rheumatology Arthritis Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 41. Novartis AG Key News & Latest Developments
Table 42. Regeneron Pharmaceuticals, Inc. Company Summary
Table 43. Regeneron Pharmaceuticals, Inc. Rheumatology Arthritis Therapeutics Product Offerings
Table 44. Regeneron Pharmaceuticals, Inc. Rheumatology Arthritis Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 45. Regeneron Pharmaceuticals, Inc. Key News & Latest Developments
Table 46. Pfizer, Inc. Company Summary
Table 47. Pfizer, Inc. Rheumatology Arthritis Therapeutics Product Offerings
Table 48. Pfizer, Inc. Rheumatology Arthritis Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 49. Pfizer, Inc. Key News & Latest Developments
Table 50. Bristol-Myers Squibb Company Company Summary
Table 51. Bristol-Myers Squibb Company Rheumatology Arthritis Therapeutics Product Offerings
Table 52. Bristol-Myers Squibb Company Rheumatology Arthritis Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 53. Bristol-Myers Squibb Company Key News & Latest Developments
Table 54. F. Hoffmann-La Roche Ltd. Company Summary
Table 55. F. Hoffmann-La Roche Ltd. Rheumatology Arthritis Therapeutics Product Offerings
Table 56. F. Hoffmann-La Roche Ltd. Rheumatology Arthritis Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 57. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 58. UCB S.A. Company Summary
Table 59. UCB S.A. Rheumatology Arthritis Therapeutics Product Offerings
Table 60. UCB S.A. Rheumatology Arthritis Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 61. UCB S.A. Key News & Latest Developments
Table 62. Johnson & Johnson Services, Inc. Company Summary
Table 63. Johnson & Johnson Services, Inc. Rheumatology Arthritis Therapeutics Product Offerings
Table 64. Johnson & Johnson Services, Inc. Rheumatology Arthritis Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 65. Johnson & Johnson Services, Inc. Key News & Latest Developments
Table 66. Amgen, Inc. Company Summary
Table 67. Amgen, Inc. Rheumatology Arthritis Therapeutics Product Offerings
Table 68. Amgen, Inc. Rheumatology Arthritis Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 69. Amgen, Inc. Key News & Latest Developments
List of Figures
Figure 1. Rheumatology Arthritis Therapeutics Segment by Type in 2023
Figure 2. Rheumatology Arthritis Therapeutics Segment by Application in 2023
Figure 3. Global Rheumatology Arthritis Therapeutics Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Rheumatology Arthritis Therapeutics Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Rheumatology Arthritis Therapeutics Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Rheumatology Arthritis Therapeutics Revenue in 2023
Figure 8. By Type - Global Rheumatology Arthritis Therapeutics Revenue Market Share, 2019-2030
Figure 9. By Application - Global Rheumatology Arthritis Therapeutics Revenue Market Share, 2019-2030
Figure 10. By Type - Global Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Rheumatology Arthritis Therapeutics Revenue Market Share, 2019-2030
Figure 12. By Application - Global Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Rheumatology Arthritis Therapeutics Revenue Market Share, 2019-2030
Figure 14. By Region - Global Rheumatology Arthritis Therapeutics Revenue Market Share, 2019-2030
Figure 15. By Country - North America Rheumatology Arthritis Therapeutics Revenue Market Share, 2019-2030
Figure 16. US Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Rheumatology Arthritis Therapeutics Revenue Market Share, 2019-2030
Figure 20. Germany Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 21. France Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Rheumatology Arthritis Therapeutics Revenue Market Share, 2019-2030
Figure 28. China Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 32. India Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Rheumatology Arthritis Therapeutics Revenue Market Share, 2019-2030
Figure 34. Brazil Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Rheumatology Arthritis Therapeutics Revenue Market Share, 2019-2030
Figure 37. Turkey Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Rheumatology Arthritis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 41. AbbVie Rheumatology Arthritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Boehringer Ingelheim GmbH Rheumatology Arthritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Novartis AG Rheumatology Arthritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Regeneron Pharmaceuticals, Inc. Rheumatology Arthritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Pfizer, Inc. Rheumatology Arthritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Bristol-Myers Squibb Company Rheumatology Arthritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. F. Hoffmann-La Roche Ltd. Rheumatology Arthritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. UCB S.A. Rheumatology Arthritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Johnson & Johnson Services, Inc. Rheumatology Arthritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Amgen, Inc. Rheumatology Arthritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
